Table 3.
Cost-Effectiveness of Providing All Basic Recommended Care Processes Pertaining to Blood Glucose Management
| Treatment Goal | Annual Per-Patient Costs* | Percentage of All Patients Achieving Goal | Incremental Cost Per Patient Newly Achieving Goal |
|---|---|---|---|
| Goal defined as HbA1c <7% | |||
| Status quo scenario | U.S.$503.38 | 37% | — |
| Improved care scenario | U.S.$830.39 | 51% | — |
| Difference between scenarios | U.S.$327.01 | 14% | U.S.$2,336 |
| Goal defined as HbA1c <8% | |||
| Status quo scenario | U.S.$503.38 | 62% | — |
| Improved care scenario | U.S.$830.39 | 72% | — |
| Difference between scenarios | U.S.$327.01 | 10% | U.S.$3,270 |
| Goal defined as HbA1c ≤9% | |||
| Status quo scenario | U.S.$503.38 | 79% | — |
| Improved care scenario | U.S.$830.39 | 85% | — |
| Difference between scenarios | U.S.$327.01 | 6% | U.S.$5,450 |
| Goal defined as moving from above to below any of the thresholds | |||
| Difference between scenarios | U.S.$327.01 | 29% | U.S.$1,128 |
*
The improved care scenario involved providing 100% of basic recommended care processes. Because these care processes do not depend on the HbA1c goal selected, costs are the same across all three goals.